High Blood Pressure Study

This research study investigates a new treatment for high blood pressure, also known as hypertension (HTN). HTN is the leading risk factor for cardiovascular disease and premature mortality globally, with its prevalence increasing, particularly in low- to middle-income countries. The study focuses on evaluating a novel gene therapy that targets a specific gene responsible for producing a protein involved in the regulation of blood pressure. By reducing levels of this protein, the study aims to normalise blood pressure in participants with mild to moderate HTN.